Clinical Trials on Ismétlődő B akut limfoblasztos leukémia
Total 1933 results
-
German CLL Study GroupMundipharma Pte Ltd.; Roche Pharma AGCompletedChronic Lymphocytic LeukemiaGermany
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany
-
Assistance Publique Hopitaux De MarseilleUnknownChronic Lymphocytic LeukemiaFrance
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
M.D. Anderson Cancer CenterGenentech, Inc.; OSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Brno University HospitalUnknownChronic Lymphocytic LeukemiaCzechia
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminatedChronic Lymphocytic LeukemiaItaly
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicAustralia, Brazil, Spain, Italy, Canada, Germany, Chile, Mexico, France, Argentina, Croatia, Russian Federation, Slovakia, Turkey, Poland, Czechia, New Zealand, Portugal, Greece
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, Canada, Spain, Australia, Italy, United Kingdom, Belgium, Croatia, France, Hungary, Poland, Romania, Czechia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Boehringer IngelheimWithdrawnLeukemia, Lymphocytic, Chronic, B-Cell
-
Hoffmann-La RocheCompleted
-
University Hospital, ToursRoche Pharma AG; French Innovative Leukemia OrganisationCompleted
-
Genentech, Inc.Terminated
-
M.D. Anderson Cancer CenterCLL Global Research Foundation AllianceWithdrawn
-
SCRI Development Innovations, LLCGlaxoSmithKline; NovartisCompletedChronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Assiut UniversityUnknownChronic Lymphocytic Leukemia
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawn
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaFrance, United States, Russian Federation, Czech Republic, Australia, United Kingdom, Italy, Brazil, Israel, Poland, Ukraine, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); FDA Office of Orphan Products DevelopmentCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupCompleted
-
Technische Universität DresdenUniversity Hospital Schleswig-Holstein; University Hospital of Cologne; University... and other collaboratorsCompletedChronic Lymphatic LeukemiaGermany
-
Astellas Pharma Europe B.V.CompletedChronic Lymphocytic LeukemiaRussian Federation
-
Thomas KippsBayerTerminatedChronic Lymphocytic LeukemiaUnited States
-
Karolinska University HospitalCompleted
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellJapan
-
Brno University HospitalFaculty Hospital Kralovske Vinohrady; University Hospital Hradec Kralove; General...CompletedChronic Lymphocytic LeukemiaCzech Republic
-
Seagen Inc.Genentech, Inc.CompletedLeukemia, Lymphocytic, ChronicUnited States
-
AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaUnited States, Australia, Israel, Poland, Ukraine
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Leukemia Research FundMedical Research CouncilCompletedLeukemiaUnited Kingdom, Italy, New Zealand, Ireland, Croatia, Russian Federation, Greece, Argentina
-
Genzyme, a Sanofi CompanyTerminatedChronic Lymphocytic LeukemiaMacedonia, The Former Yugoslav Republic of, Bosnia and Herzegovina, Israel
-
La Jolla Pharmaceutical CompanyCompletedChronic Lymphocytic LeukemiaUnited States
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.Completed
-
Bristol-Myers SquibbCompletedChronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Novartis PharmaceuticalsXOMA (US) LLCTerminatedChronic Lymphocytic LeukemiaUnited States